Silence Therapeutics PLC (SLN) — Cash Flow-to-Debt Ratio
Silence Therapeutics PLC (SLN) has a Cash Flow-to-Debt Ratio of 0.02x as of June 2026, meaning its operating cash flow of $1.49 Million could theoretically repay 0% of its total liabilities ($67.94 Million) in one year. See Silence Therapeutics PLC financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Silence Therapeutics PLC Cash Flow-to-Debt Ratio (1995–2025)
Historical debt coverage capacity for Silence Therapeutics PLC across 31 annual periods. For the full cash flow conversion analysis, see Silence Therapeutics PLC cash conversion from operations.
Annual Cash Flow-to-Debt Ratio for Silence Therapeutics PLC (1995–2025)
Year-by-year debt coverage analysis for Silence Therapeutics PLC. Check Silence Therapeutics PLC cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.90x | $-62.27 Million | $69.14 Million | ▲ +8.7% |
| 2024 | -0.99x | $-54.05 Million | $54.80 Million | ▼ -93.3% |
| 2023 | -0.51x | $-39.35 Million | $77.12 Million | ▲ +23.6% |
| 2022 | -0.67x | $-57.04 Million | $85.43 Million | ▼ -737.3% |
| 2021 | 0.10x | $9.19 Million | $87.67 Million | ▲ +174.8% |
| 2020 | -0.14x | $-10.78 Million | $76.91 Million | ▼ -304.2% |
| 2019 | 0.07x | $1.73 Million | $25.17 Million | ▲ +101.6% |
| 2018 | -4.38x | $-16.76 Million | $3.83 Million | ▼ -21.1% |
| 2017 | -3.61x | $-9.60 Million | $2.66 Million | ▲ +42.2% |
| 2016 | -6.25x | $-10.07 Million | $1.61 Million | ▲ +15.3% |
| 2015 | -7.38x | $-8.26 Million | $1.12 Million | ▼ -57.2% |
| 2014 | -4.70x | $-9.46 Million | $2.01 Million | ▼ -19.9% |
| 2013 | -3.92x | $-6.76 Million | $1.72 Million | ▲ +22.9% |
| 2012 | -5.08x | $-4.88 Million | $959.00K | ▼ -25.4% |
| 2011 | -4.06x | $-5.11 Million | $1.26 Million | ▲ +35.2% |
| 2010 | -6.26x | $-10.55 Million | $1.69 Million | ▼ -183.2% |
| 2009 | -2.21x | $-4.65 Million | $2.10 Million | ▲ +70.4% |
| 2008 | -7.47x | $-6.98 Million | $935.00K | ▼ -251.0% |
| 2007 | -2.13x | $-3.83 Million | $1.80 Million | ▲ +44.9% |
| 2006 | -3.86x | $-4.03 Million | $1.04 Million | ▼ -106.1% |
| 2005 | -1.87x | $-2.78 Million | $1.49 Million | ▲ +36.1% |
| 2004 | -2.93x | $-2.48 Million | $846.00K | ▼ -88.2% |
| 2003 | -1.56x | $-2.04 Million | $1.31 Million | ▲ +13.0% |
| 2002 | -1.79x | $-1.84 Million | $1.03 Million | ▲ +43.1% |
| 2001 | -3.15x | $-2.28 Million | $725.00K | ▼ -6.1% |
| 2000 | -2.97x | $-2.86 Million | $964.00K | ▼ -319.4% |
| 1999 | -0.71x | $-1.13 Million | $1.60 Million | ▲ +76.4% |
| 1998 | -3.00x | $-1.81 Million | $603.00K | ▼ -26.3% |
| 1997 | -2.37x | $-1.52 Million | $640.00K | ▼ -36.1% |
| 1996 | -1.74x | $-727.00K | $417.00K | ▲ +31.0% |
| 1995 | -2.53x | $-761.00K | $301.00K | — |